GenesisCare and Elekta in USD 100 Million Strategic Partnership
By MedImaging International staff writers Posted on 04 Apr 2016 |
Elekta (Stockholm, Sweden), a company pioneering cancer and brain disorders treatment solutions, has announced a multiyear strategic partnership with GenesisCare (Alexandria, NSW, Australia), the largest radiotherapy provider in Australia.
The eight-year partnership is valued at more than USD 100 million and includes Elekta's Leksell Gamma Knife radiosurgery system, brachytherapy systems, Versa HD linear accelerators, software, and services for use in GenesisCare cancer treatment centers in Australia, the UK, and in new markets.
The agreement also includes Elekta’s MOSAIQ enterprise licensing system, and the METRIQ software. The MOSAIQ software enables a completely optimized and automated workflow across a global enterprise, while the METRIQ software is an integrated cancer registry, including reporting, and follow-up analysis.
Dan Collins, managing director of GenesisCare, said, "Elekta is a natural partner for GenesisCare. We want all cancer patients to receive rapid access to high quality care. Elekta helps us make this happen with their suite of technology solutions, global reach and commitment to innovation. The MR-linac is a game changer. We expect cancer patients, including those receiving treatment for prostate, breast and other cancers, to benefit from this innovation. Anything that improves the accuracy of treatment and provides a smoother patient experience should improve outcomes."
Related Links:
Elekta
GenesisCare
The eight-year partnership is valued at more than USD 100 million and includes Elekta's Leksell Gamma Knife radiosurgery system, brachytherapy systems, Versa HD linear accelerators, software, and services for use in GenesisCare cancer treatment centers in Australia, the UK, and in new markets.
The agreement also includes Elekta’s MOSAIQ enterprise licensing system, and the METRIQ software. The MOSAIQ software enables a completely optimized and automated workflow across a global enterprise, while the METRIQ software is an integrated cancer registry, including reporting, and follow-up analysis.
Dan Collins, managing director of GenesisCare, said, "Elekta is a natural partner for GenesisCare. We want all cancer patients to receive rapid access to high quality care. Elekta helps us make this happen with their suite of technology solutions, global reach and commitment to innovation. The MR-linac is a game changer. We expect cancer patients, including those receiving treatment for prostate, breast and other cancers, to benefit from this innovation. Anything that improves the accuracy of treatment and provides a smoother patient experience should improve outcomes."
Related Links:
Elekta
GenesisCare
Latest Industry News News
- Hologic Acquires UK-Based Breast Surgical Guidance Company Endomagnetics Ltd.
- Bayer and Google Partner on New AI Product for Radiologists
- Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement
- IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering
- International Societies Suggest Key Considerations for AI Radiology Tools
- Samsung's X-Ray Devices to Be Powered by Lunit AI Solutions for Advanced Chest Screening
- Canon Medical and Olympus Collaborate on Endoscopic Ultrasound Systems
- GE HealthCare Acquires AI Imaging Analysis Company MIM Software
- First Ever International Criteria Lays Foundation for Improved Diagnostic Imaging of Brain Tumors
- RSNA Unveils 10 Most Cited Radiology Studies of 2023
- RSNA 2023 Technical Exhibits to Offer Innovations in AI, 3D Printing and More
- AI Medical Imaging Products to Increase Five-Fold by 2035, Finds Study
- RSNA 2023 Technical Exhibits to Highlight Latest Medical Imaging Innovations
- AI-Powered Technologies to Aid Interpretation of X-Ray and MRI Images for Improved Disease Diagnosis
- Hologic and Bayer Partner to Improve Mammography Imaging
- Global Fixed and Mobile C-Arms Market Driven by Increasing Surgical Procedures